Morphinanverbindungen

European patent · EP2522667 · In force

Register entry

Publication number
EP2522667
Application number
EP12176476
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 30, 2008
Published
Nov 14, 2012
Granted
Aug 20, 2014
Protection ends at the latest
Apr 29, 2028
Next annual fee due
Apr 30, 2026
IPC classes
C07D 471/08 (2006.01)
C07B 59/00 (2006.01)
A61K 31/439 (2006.01)
A61P 11/14 (2006.01)
Priority
US 915130 P 01.05.2007
US 916662 P 08.05.2007
US 976044 P 28.09.2007
Divided from
EP11000764
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  2. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  3. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  4. Sep 23, 2014

    Agent entered

    Representative
    Marks & Clerk (Luxembourg) LLP, Dreikönigstrasse 31a, 8002 Zürich

    Published in Swissreg on 23.09.2014

  5. Aug 20, 2014

    Granted

    Published in Swissreg on 20.08.2014

Parties

Holder

Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals Inc.

99 Hayden Avenue, Suite 100, Lexington, MA 02421, US

Agent

Marks & Clerk (Luxembourg) LLP

Dreikönigstrasse 31a, 8002 Zürich

Inventor

Tung, Robert

Lexingon, MA 02421, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.